1. Home
  2. NXJ vs CTKB Comparison

NXJ vs CTKB Comparison

Compare NXJ & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New Jersey Qualified Municipal Fund

NXJ

Nuveen New Jersey Qualified Municipal Fund

HOLD

Current Price

$12.69

Market Cap

503.5M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.67

Market Cap

433.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXJ
CTKB
Founded
1999
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
503.5M
433.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NXJ
CTKB
Price
$12.69
$4.67
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$5.88
AVG Volume (30 Days)
74.9K
1.9M
Earning Date
01-01-0001
11-05-2025
Dividend Yield
3.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$196,828,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.06
$2.37
52 Week High
$12.24
$7.30

Technical Indicators

Market Signals
Indicator
NXJ
CTKB
Relative Strength Index (RSI) 49.98 41.78
Support Level $12.58 $4.79
Resistance Level $12.77 $5.16
Average True Range (ATR) 0.10 0.24
MACD -0.01 -0.12
Stochastic Oscillator 42.67 4.17

Price Performance

Historical Comparison
NXJ
CTKB

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: